Advanced Medical Solutions Grp PLC Directors' Shareholdings (1361X)
May 04 2016 - 2:01AM
UK Regulatory
TIDMAMS
RNS Number : 1361X
Advanced Medical Solutions Grp PLC
04 May 2016
4 May 2016
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Directors' Shareholdings
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
leading developer and manufacturer of advanced products for the
global surgical and wound care markets, announces that the Trust
which manages the Deferred Share Bonus Plan on behalf of the
employees of AMS has purchased ordinary shares of 5 pence each
("Ordinary Shares") on 3 May 2016, at a price of 183 pence per
share on behalf of Chris Meredith and Mary Tavener as part of the
Deferred Share Bonus Plan and, under the terms of the Plan, these
shares will be held in trust on their behalf.
Following these transactions the beneficial ownership of Chris
Meredith and Mary Tavener is as follows:
Director Date purchased Shares Resultant % of issued
purchased holding share
capital
================== ================ =========== ========== ============
Chris Meredith
Chief Executive 3 May
Officer 2016 2,431 1,190,322 0.6
================== ================ =========== ========== ============
Mary Tavener
Chief Financial 3 May
Officer 2016 2,431 1,828,129 0.9
================== ================ =========== ========== ============
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Group Finance Director
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Gary Clarence / Daniel Adams
/ Patrick Robb
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 510 employees. For more
information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFIDEIIVIIR
(END) Dow Jones Newswires
May 04, 2016 02:01 ET (06:01 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Sep 2023 to Sep 2024